Differing Completion Rates of DIABETES Education on Patient Reported Outcomes

NCT ID: NCT06419907

Last Updated: 2025-09-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-16

Study Completion Date

2025-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical feasibility trial is to test the impact of differing completion rates of a face-to-face diabetes self-management education programme on patient-reported outcomes measuring self-care, diabetes distress and quality of life in people with type 2 diabetes. The main question it aims to answer is:

1\. What is the impact of differing completion rates of DSME programmes on ability to self-care (primary outcome), diabetes distress and health related quality of life in type 2 diabetes.

Researchers will compare participants across four study groups (Group 1 will receive a full DSME programme, Group 2 will receive 60%, Group 3 will receive 10% and Group 4 will have delayed education) to see if patients who attend minimal aspects (10%) of diabetes self-management education programmes gain clinically significant improvements in ability to self-care compared to those who do not attend and if the nationally accepted 60 % completion rate is as effective as 100% completion.

Participants will:

* complete three validated patient reported outcome measures testing self care activities, diabetes distress and health related quality of life.
* Attend structured diabetes self-management education of differing completion rates dependent on the group they have been allocated to.
* repeat the same three patient reported outcome measures 2-4 months after intervention. For participants in group 4 this will be 3-4 months from baseline.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Structured diabetes self-management education (DSME) is internationally recommended for all people with newly diagnosed type 2 diabetes and is designed to support patients in self-managing their condition and prevent associated long-term complications. DSME is proven to be as effective as pharmacotherapy in preventing diabetes associated morbidity and premature mortality but attendance at both a national and local level remains poor. Local records suggest that of those that start DSME (9%) only 12.6% complete the programme. Attendance at DSME is currently benchmarked as having completed a registration form and had at least one active engagement with a programmes content, with 'completion' measured against ≥60% completion despite landmark trials reporting outcomes based on the full completion of a programme. Little is known, of the effectiveness of DSME on the psychological and emotional health of people with diabetes who complete less than the full DSME programme.

This feasibility study will test the impact of differing completion rates of a face-to-face DSME programme on patient reported outcomes measuring self-care, diabetes distress and quality of life in people with type 2 diabetes.

Using a quantitative approach, a single centre, randomised feasibility study will be conducted, aiming to recruit 120 eligible people with type 2 diabetes due to attend a secondary care diabetes clinic in the Northwest UK for specialist support, education and advice. Participants will be randomised into one of four groups: Group 1 will receive a full DSME programme, Group 2 will receive 60%, Group 3 will receive 10% and Group 4 will have delayed education. Normal clinical care will continue. Preliminary outcomes (psychometric questionnaire scores measuring ability to self-care, diabetes distress and health related quality of life) will be evaluated at baseline and 3-4 months post-intervention. Measures of feasibility (eligibility, recruitment and retention rates) will be reported.

Whilst the current literature evidences the clear benefits for people with type 2 diabetes attending DSME programmes, there is minimal understanding of the benefits of partial DSME completion on a person's ability to self-care despite national consensus accepting 60% attendance as 'completed'. The proposed research aims to test the feasibility of conducting a full randomised control trial to evaluate the effectiveness of DSME programmes on psychometric outcomes with differing completion rates

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2 Patient Education as Topic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

100% of a face to face 6 hour structured diabetes self management education session

Group Type ACTIVE_COMPARATOR

Type 2 Live Well (structured diabetes self management education programme)

Intervention Type BEHAVIORAL

Structured diabetes self management education programme designed to support those with type 2 diabetes self care and prevent long term associated complications.

Group 2

60% of a face to face 6 hour structured diabetes self management education session. Total attendance will be 3 hours 36 minutes.

Group Type EXPERIMENTAL

Type 2 Live Well (structured diabetes self management education programme)

Intervention Type BEHAVIORAL

Structured diabetes self management education programme designed to support those with type 2 diabetes self care and prevent long term associated complications.

Group 3

10% of a face to face 6 hour structured diabetes self management education session. Total attendance will be 36 minutes.

Group Type EXPERIMENTAL

Type 2 Live Well (structured diabetes self management education programme)

Intervention Type BEHAVIORAL

Structured diabetes self management education programme designed to support those with type 2 diabetes self care and prevent long term associated complications.

Group 4

Will not attend a face to face 6 hour structured diabetes self management education session

Group Type ACTIVE_COMPARATOR

Type 2 Live Well (structured diabetes self management education programme)

Intervention Type BEHAVIORAL

Structured diabetes self management education programme designed to support those with type 2 diabetes self care and prevent long term associated complications.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Type 2 Live Well (structured diabetes self management education programme)

Structured diabetes self management education programme designed to support those with type 2 diabetes self care and prevent long term associated complications.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with a diagnosis of type 2 diabetes aged ≥18 years of age referred to the Diabetes centre who are able to provide informed consent and are responsible for daily management of their diabetes will be screened for entry into the study

Exclusion Criteria

The following patients will be excluded entry into the study:

* Lack capacity to make an informed decision.
* A diagnosis of type 1, type 3c, Maturity-onset diabetes of the young (MODY) or gestational diabetes.
* Received structured education for their diabetes within the last 12 months either online or face to face.
* Require 1:1 education support e.g., requires interpreter.
* Patients unable to attend for structured classroom education e.g., housebound.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St Helens & Knowsley Teaching Hospitals NHS Trust

OTHER

Sponsor Role collaborator

University of Liverpool

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gemma A Lewis

Role: PRINCIPAL_INVESTIGATOR

University of Liverpool

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Diabetes Centre, St Helens Hospital

St Helens, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Lewis G, Irving G, Wilding J, Hardy K. Evaluating the impact of differing completion rates of a face-to-face DIABETES self-management education programme on Patient Reported Outcome measures (DIABETES PRO): A feasibility trial protocol. Diabet Med. 2024 Dec;41(12):e15430. doi: 10.1111/dme.15430. Epub 2024 Sep 5.

Reference Type DERIVED
PMID: 39235931 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://datacat.liverpool.ac.uk/

Secure online environment for University of Liverpool Researchers to deposit, share and promote data and information

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

337691

Identifier Type: OTHER

Identifier Source: secondary_id

UoL001848

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.